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Abstract
Object: Lactobacillus acidophilus is a nonpathogenic member of gas-
trointestinal tract and it is widely used in fermented dairy products. 
This study aimed to assess the antimicrobial potential of two strains 
of L. acidophilus on some pathogenic bacteria frequently causing diar-
rhea or gastroenteritis.
Methods: The antibacterial activity cell free supernatant (CFS) of two 
control standard strains of L. acidophilus (L. acidophilus-la5 and L. 
acidophilus against five control standard strains of bacteria causing 
diarrhea; Enterotoxogenic Escherichia coli (ETEC), Enterohaemorrhagic 
E. coli O157:H7(EHEC) Salmonella typhimurium Shigella flexeneri and 
Staphylococcus aureus were determined using agar well diffusion 
method. The sensitivity of the pathogenic bacteria to the CFS of each 
L. acidophilus in relation to time was determined by standard plate 
count .The antibiotic susceptibility tests of 20 antibiotics against test-
ed organisms with and without CFS were assessed by disc diffusion 
method. The minimum inhibitory concentration (MIC) of ciprofloxacin 
with and without CFS was determined by tube dilution method. 
Results: Both Lactobacilli strains decrease the colony count of tested 
strains by more than 90% after 60 min contact time. Both Lactobacilli 
strains significantly improve the antibacterial effect of tested antibiot-
ics against ETEC, S. typhimurium and S. aureus, and S. flexeneri (P< 
0.05). The MIC of ciprofloxacin alone against all tested strains was 
15.625 μg/ml, while when combined with both Lactobacilli CFSs, the 
MIC decreased significantly to 0.488 μg/ml for ETEC, S. typhimurium, 
and S. flexeneri and to 0.977 μg/ml for EHEC and S. aureus (P= 0.000). 
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Introduction
Infective bacterial diarrhea is a global health 
problem especially in young children in developing 
countries with rotavirus is the most common identi-
fied pathogen [1]. Many bacterial species were impli-
cated as a cause of infective diarrhea as Salmonella 
spp., Campylobacter spp., Shiga toxin-producing E. 
coli O157:H7 strain, Shigella spp., Vibrio spp.; and 
Yersinia spp. Other diarrheagenic E. coli in particular 
enterotoxigenic E. coli and enteroaggregative E. coli 
are increasingly being reported as causes of acute 
diarrhea [2].
Oral rehydration solution and antimicrobials are 
the main treatments for acute diarrhea. However, 
when diarrheal patients were given probiotics prior 
to or during hospitalization, a reduction in the fre-
quency of diarrheal symptoms has been reported in 
both adults and children [1, 3].
Probiotics are preparations of living bacteria and 
yeasts that possess a beneficial health effect when 
administrated in adequate amounts [1, 4].They have 
been extensively studied for their beneficial effects 
in preventing and treating many conditions, includ-
ing the treatment of lactose intolerance, traveller’s 
diarrhea and the prevention and treatment of hos-
pital acquired diarrhea[5, 6]. Previous studies have 
evaluated the effect of Lactobacillus rhamnosus on 
colonization of rotavirus and found a potential an-
timicrobial effect against it [7]. It has been reported 
that most probiotics are well tolerated with rare 
adverse effect and can be safely used in patients 
with underlying chronic diseases or in those on im-
munosuppressive therapy [1].
Lactic acid bacteria are a group of Gram-positive 
bacilli and cocci occurring naturally in gastrointesti-
nal tract, plants and fermented foods, such as dairy 
products, meat and alcoholic beverages [4]. Most 
probiotics commercially available today belong to the 
genera Lactobacillus and Bifidobacterium. They are 
the most important group of microorganism used in 
food fermentations. They inhibit food spoilage and 
pathogenic bacteria by producing antimicrobial sub-
stances such as lactic acid, hydrogen peroxide and 
bacteriocins [8]. Several mechanisms by which pro-
biotics in vivo mediate their health benefits in the 
host; first, certain probiotics have antimicrobial ac-
tivity and can exclude or inhibit pathogens; second, 
they can enhance the intestinal epithelial barrier; 
third, probiotic bacteria are believed to modulate 
the host immune response [4].
The aim of this study was to investigate the an-
timicrobial potential of two L. acidophilus strain on 
pathogenic bacteria frequently causing diarrhea or 
gastroenteritis with and without antibiotics.
Materials and Methods 
The test organisms
Five standard strains of diarrhea causing bacteria; 
Enterotoxogenic E. coli (ETEC) (ATCC 25922), Enter-
ohaemorrhagic E. coli O157:H7 (EHEC) (ATCC 51659), 
S. typhimurium (ATCC 25566), S. flexeneri(ATCC 
Conclusion: living L. acidophilus strains could be used in prevention 
and treatment of diarrhea caused by certain bacterial pathogens, ei-
ther in fermented milk/ yoghurt or as mediations. 
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29903, CCM 4422) and S. aureus (ATCC 13565) 
were used in this study. The test organisms were 
grown in Brain Heart Infusion broth (Oxoid Ltd., Bas-
ingstoke, UK) and incubated at 35°C for 18 hrs. The 
concentrations of the organisms were determined 
by spectrophotometric method and standardized 
for all organisms at 103 cfu/ml [9].
Preparation of cell-free L. acidophilus 
culture supernatants
Two standard strains of L. acidophilus (L. acido-
philus-la5 (L1) and L. acidophilus (ATCC 4356, DSM 
20079) (L2) were grown in MRS broth (Oxoid Ltd., 
Basingstoke, UK) at 35˚C for 18 hrs and adjusted 
to 0.5 McFarland. The cultures were centrifuged at 
10000xg for 15 min and the resulted supernatant 
was designated crude cell –culture free supernatant 
(CFS). These supernatants were used immediately or 
stored at -20˚C until needed for antibacterial activ-
ity [10].
Determination of the antibacterial activity 
of L. acidophilus 
The antibacterial effect of L1 and L2 was inves-
tigated by the following methods:
1.  Agar well diffusion method (Qualitative in-
hibitory effect of CFS of lactobacilli strains). 
Agar well diffusion method was used as de-
scribed by Wolf and Gibbones [11]. Briefly the 
freshly prepared inoculum (108 CFU/ mL) was 
swabbed all over the surface of the Muller 
Hinton plate (Oxoid Ltd., Basingstoke, UK) us-
ing sterile cotton swab. Five wells were bored 
in the medium with the help of sterile cork-
borer having 5-mm diameter and were labeled 
properly. Then 50 μL of each CFS was added 
to each well, 50 μL of sterile nutrient broth 
was added to a well as a control. The experi-
ment was done in triplicate. All plates were 
incubated at 37°C for 24 hours. After incuba-
tion, zones of inhibition (IZ) were measured.
2.  Standard plate count (Quantitative inhibitory 
effect of CFS of lactobacilli strains): Equal 
amounts of CFS of each L. acidophilus and 
each test organism at 103 CFU/ml were mixed 
in a sterile flask. The mixture was stirred gen-
tly. 100 µl was immediately transferred to nu-
trient agar (0 contact time) and incubated at 
35°C for 18-24 hours. 100 µl sterile MRS broth 
was used as a negative control. This procedure 
was repeated at intervals of 10 minutes up to 
60 minutes (0, 10, 20, 30,40,50,60 minutes). 
Standard plate count was evaluated after in-
cubation [9]. 
3.  Antibiotic susceptibility test with and without 
lactobacilli. This test was done by using Kirby-
Bauer disc diffusion method. Muller-Hinton 
plates were inoculated by swabbing the tested 
organism after dilution of 108 cfu/ml organ-
isms with equal amount of nutrient broth (Ox-
oid Ltd., Hampshire, UK) onto the surface of 
agar plates. Antibiotic discs were applied and 
plates were incubated for 24 hours at 35˚C. 
The antibacterial activities of antibiotics were 
assessed by measuring the inhibition zone (IZ) 
in mm. Equal amounts of CFS of each L. aci-
dophilus and each test organism at 108 cfu/ml 
was mixed in a sterile flask at 0 contact time 
and the previous steps were performed and 
the results of both of tests were compared 
[12]. The following antibiotics discs (Oxoid Ltd., 
Hampshire, U K) were used: Rifampicin (30 
μg), Norfloxacin (10 μg), Cefepime (30 μg), 
Cefoperazone (30 μg), Chloramphenicol (30 
μg), Ampicillin/Sulbactam (20 μg), Amoxicil-
lin (10 μg), Ciprofloxacin (5 μg), Gentamycin 
(μg), Cefotraxione (CRO) with 30 μg disc con-
tent, Sulphamethoxazole/Trimethprim (25μg), 
Doxycyline (30 μg), Erythromycin (15 μg), Ami-
kacin (30 μg), Amoxicillin/Clavulanic acid (30 
μg), Vancomycin (30 μg), Meropenem (10 μg), 
Clindamycin (10 μg), Tobromycin (30 μg), Ce-
fotaxime (30 μg).
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4.  Antibacterial effect of L. acidophilus on mini-
mum inhibitory concentration (MIC) of cip-
rofloxacin against diarrhea causing bacteria. 
MIC of ciprofloxacin on tested organisms with 
and without lactobacilli supernatant were per-
formed using macro-tube dilution method. 
MICs of ciprofloxacin alone and MICs of CFS 
alone: for each organism was determined as 
described by Clinical and laboratory standards 
institute [13]. For determination of MIC of cip-
rofloxacin with lactobacilli, serial two-old dilu-
tion of ciprofloxacin in supernatant of each 
Lactobacillus CFS was prepared and inoculat-
ed with 25 μl of 108 cfu/ml of test organism 
to each tube, mixed well and incubated at 
35˚C for 18 hrs
Statistical analysis 
All statistical analysis were done using computer 
programs SPSS (Statistical Package for the Social Sci-
ence; SPSS Inc., Chicago, IL, USA) version 15 for Mi-
crosoft Windows. The independent samples t-test 
was used for comparison between the antimicrobial 
effect of antibiotic with and without L1 and L2. P 
value ≤ 0.05 was considered the cut-off value for 
statistically significance and P value ≤ 0.001 was 
considered highly significant.
Results
Both Lactobacilli (L1 and L2) strains dramatically 
reduced the colony count of tested strains; the de-
crease is directly proportional to the time of contact 
between organism and lactobacilli supernatants 
(Figure 1). We found more than 50% reduction 
in colony count of all tested organisms after ten 
minutes of contact with supernatants of both Lac-
tobacilli, except for S. aureus it needs 30 min. The 
maximal effect was on ETEC. L2 needs more con-
tact time than L1except for S. aureus. No significant 
difference between L1 and L2 supernatants in their 
antibacterial effect against tested organisms (P ≥ 
0.05).
The inhibitory diameter of L1 and L2 against test-
ed organisms are shown in Table 1. S.typhimurium 
is apparently the most affected organism although 
the differences between the two diffusion diam-
eters of L1 and L2 are non-significant (P > 0.05).
Table 1.  Inhibition zone (mm± SD) of L. 
acidophilus (L1 and L2) on tested 
organisms
Tested 
organisms
L. acidophilus-la5 
(L1) 
L. acidophilus 
ATCC 4356(L2)
EHEC 12±1 12±2
ETEC 16±2 14±1
S. typhimurium 16±1 19±2
S. flexeneri 15±1 12±1
S. aureus 12±2 14±1
Table 2 shows both Lactobacilli strains signifi-
cantly improve the antibacterial effect of tested 
antibiotics by disc diffusion method against ETEC, 
S. typhimurium and S. aureus, and S. flexeneri (P 
<0.05). It seems that the best effect of L1 and L2 
were on amoxicillin/clavulanic acid, Cefoperazone, 
clindamycin, erythromycin, rifampicin and vancomy-
cin. 
L1 and L2 potentiate the antibacterial effect of 
ciprofloxacin on Enterotoxogenic E. coli, Entero-
haemorrhagic E. coli O157:H7, S. typhimurium, S. 
flexeneri and S. aureus as the MIC of ciprofloxacin 
alone against all tested strains was 15.625 μg/ml, 
while when combined with L1 or L2 supernatant, 
the MIC significantly decreased to 0.48μg/ml, for 
ETEC, S. typhimurium, and S. flexeneri and to 0.977 
μg/ml, for EHEC and S. aureus (P= 0.000) (Figure2).
Ciprofloxacin is effective against all bacteria 
tested, and showed almost similar results (inhibi-
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Figure 1. Time kill curve of L. acidophilus on tested organisms:
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Figure 2. MICs of Ciprofloxacin (μg/ml( with and without L. acidophilus (L1 and L2) against tested organisms
Table 2.  The antimicrobial effect of different antibiotics on tested organisms with and without L1 and 
L2 by disc diffusion methods (mm)
This article is available from: www.iajaa.org   /   www.medbrary.com
S. aureus+L 2 S. aureus +L 1S . aureus  S . flexeneri+L 2S . flexeneri+L 1S . flexeneriS . typhimurium+L 2S . typhimurium+L 1S . typhimuriumETEC+L2 ETEC+L1 ETEC EHEC+L2 EHEC+L1 EHEC Antibiotic
13 =R12=R9=R  18=I19=I18=I12=R  13=R12=R0=R0=R0=R0=R  0=R  0=R  A moxicillin
22=S23=S17=S 24=S18=S15=S0=R10=R0=R0=R0=R0=R0=R0=R  0=R  A mpicillin/Sulbactam 
16=R13=R  10=R15=I 16=I15=I 21=S21=S17=I19=R21=R18=R15=I14=I12=RA moxicillin/C lavulanic acid
17=I 16=I16=I 0=R0=R0=R11=R10=R0=R27=S26=S20=S25=SS=2315=IC efepime
15=R16=I15=R35=S25=S20=I25=S28=S25=S 28=S28=S23=S21=S21=S20=IC efoper azone
23=S23=S 23=S 40=S40=S24=S12=R12=R  5=R19=I19=I17=I38=S 40=S 24=S C efotaxime
27=S26=S23=S 40=S37=S23=S12=R20=I12=R31=S31=S23=S25=S25=S20=IC efotr axione
18=S17=S 16=S 20=S20=S17=S25=S22=S0=R12=R0=R0=R0=R19=S0 = RV ancomycin
24=S23=S 23=S 32=S23=S21=S 44=S48=S36=S 44=S43=S35=S26=S 25=S 23=S M er openem
26=S28=S 21=S 40=S44=S 35=S23=S46=S0=R0=R9=R0=R25=S20=I0=RC lindamycin
30=S30=S29=S 25=S35=S25=S32=S32=S28=S44=S34=S26=S31=S 28=S 28=S C hlor amphenicol
38=S40=SR =1532=S20=S10=R43=S38=S16=R43=S48=S17=I16=R21=S13=RR ifampicin 
32=S33=S30=S 40=S33=S30=S39=S40=S32=S 40=S40=S35=S32=S 30=S 30=S Nor floxacin
33=S34=S32=S46=S46=S30=S42=S38=S35=S 41=S43=S35=S32=S  31=S 31=S  C ipr ofloxacin
22=S22=S21=S 30=S25=S17=S28=S35=S21=S 37=S28=S25=S21=S 20=S 20=S G entamycin
20=S20=S 18=S 21=S24=S21=S30=S28=S19=S 21=S20=S15=S25=S 22=S 16=S T obr omycin
30=S32=S20=S 28=S24=S16=S38=S43=S23=S25=S23=S16=S23=S31=S18=IDoxycyline
30=S32=S13=R25=S11=R11=R35=S25=S0=R38=S38=S10=R0=R18=I0= RE r ythr omycin
22=S24=S20=S 30=S31=S 20=S23=S24=S 21=S 33=S27=S21=S26=S 26=S 21=S A mikacin
30=S32=S30=S 46=S36=S24=S35=S 35=S27=S34=S31=S25=S32=S 32=S 27=S Sulphamethoxazole/T r imethpr im 
0.046*0.043*-0.033*0.036*-0.014*0.003*-0.04*0.08-0.190.054-P value
R: Resistant, S: Susceptible, I: Intermediate resistant, *significant
THE INTERNATIONAL ARABIC JOURNAL OF ANTIMICROBIAL AGENTS
ISSN 2174-9094
2015
Vol. 5 No. 1:2 
doi: 10.3823/764
© Under License of Creative Commons Attribution 3.0 License 7
tion zone) with or without lactobacilli strains (L1 
and L2) as shown in Table 2 and Figure 2. How-
ever, their MICs are highly different according to the 
method used and the difference in dilution factors. 
The inhibition zones of ETEC, S. typhimurium and 
S. flexeneri are considerably increased in presence 
of L1 and L2 with ciprofloxacin.
Discussion
We have studied the effect of Lactobacillus aci-
dophilus on diarrhea causing bacteria; E. coli, S. ty-
phimurium, S. flexeneri and S. aureus. The Lacto-
bacilli have been shown to possess inhibitory activ-
ity toward the growth of pathogenic bacteria. Our 
results revealed that the count of E. coli O157:H7 
decreased after 60 minutes from 240 to 17 cfu af-
ter mixing with LB-La5 (L1) and from 279 to 12 cfu 
after mixing with LB- ATCC 4356 (L2). As regarding 
the effect of L1 on control E-coli strain, the count 
of the latter deceased from 370 to 6 cfu after 60 
minutes, while the count deceased from 350 to 11 
cfu after 60 minutes with L2. In agreement with 
these results, Ogawa et al. [14] had documented the 
bactericidal activities of L. acidophilus against E.coli. 
Abdel-Daim et al.[15] studied the probiotic po-
tential and antagonistic activities of 32 Lactobacil-
lus isolates against S. typhi and found that twelve 
Lactobacillus isolates could protect against S. typhi 
infections by interference with its growth and its 
virulence properties, such as adherence, invasion, 
and cytotoxicity. These results are nearly similar to 
the results of the current study since we found de-
cease in the count of Salmonella (from 255 to18 cfu 
and from 222 to 20 cfu) after 60 minutes mixing 
with CFS of lactobacilli (LB-La5) and lactobacilli (LB- 
ATCC 4356), respectively.
This study revealed that the count of S. flexneri 
decreased to 10 cfu after contact with Lactobacillus 
(LB-La5) for 60 min, and to 15 cfu after mixing with 
LB- ATCC 4356 for 60 min. The study of Zhang et al. 
[16] has documented that lactobacilli strongly inhibit 
the gastrointestinal pathogen Shigella. 
The present study found that the count of 
S.aureus decreased from 340 to16 cfu and from 
360 to 10 cfu , respectively after mixing with (LB-
La5) and LB- ATCC 4356, over one hour. Dicks and 
Botes [17] had reported that hydrogen peroxide 
produced by some strains of Lactobacilli, effectively 
inhibits Staphylococcus aureus, and L. acidophilus 
isolated from humans due to production of bacte-
riocin and non-bacteriocin antimicrobial substances 
which are active ( both in vitro and in vivo) tests 
against Gram-positive and Gram-negative patho-
gens. Similar results were previously obtained by 
the study of Bassyouni et al. [4], where 8 strains of 
Lactobacilli isolated from different dairy products 
showed antimicrobial effects on clinical isolates of 
E.coli, Staphylococcus spp., Salmonella spp. Micro-
coccus spp. using well diffusion method and with 
inhibition zone ranging from 13 to 25 mm.
However, the result of this study disagree with 
Szymanski et al. [18] who has indicated that the 
effect of Lactobacilli was limited to the treatment 
of rotavirus induced diarrhea in children but not to 
the treatment of diarrhea of other etiology. Another 
study conducted by Szajewska et al. [19], reported 
also limitation of the therapeutic effects of probiot-
ics on watery diarrhea and viral gastroenteritis but 
not against invasive bacterial diarrhea in children.
Synergistic effect of probiotics and antibiotics 
have been studied since 1990. Tomioka et al. [20] 
has investigated the effect of ofloxacin combined 
with Lactobacillus casei against Mycobacterium 
fortuitum induced infection in mice. They found 
that multiple injections of ofloxacin (subcutaneous 
or oral) in combination with a Lactobacillus casei 
preparation LC9018 (subcutaneous), in mice infect-
ed intravenously with Mycobacterium fortuitum led 
to the following; a marked delay in the incidence 
of spinning disease, a lowered incidence of gross 
renal lesions, and an increase in the rate of elimina-
tion of organisms from the kidneys. Their result in-
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dicates synergism in the therapeutic efficacy of the 
two agents. We have studied the effect Lactobacilli 
(L1and L2) in association with 20 antibiotics using 
disc diffusion method and found that both Lactoba-
cilli significantly improve the antibacterial effect of 
tested antibiotics against ETEC, S. typhimurium and 
S. aureus, and S. flexeneri (P< 0.05). Similar results 
were reported by Ruiz et al. [21] using selected Lac-
tobacillus fermentum strain L23 and L. rhamnosus 
strain L60 as an alternative treatment to prevent or 
treat urogenital infections. Their antimicrobial ac-
tivity tests of L23 and L60 were performed by a 
disc diffusion method against 207 bacterial isolates 
from female presenting with urinary or genital in-
fections. Their results showed 100% of the clinical 
isolates were susceptible to the antimicrobial sub-
stances produced by L23 and L60, and the selected 
lactobacilli produced larger inhibition zones when 
compared to several antibiotics commonly used for 
treating these infections. Synergistic interactions 
and indifferent interactions were recorded in 68.6% 
and 31.4% of the cases, respectively, while no an-
tagonistic interactions were observed. Also, Hussein 
et al. [22] found that L. acidophilusis specifically an-
tagonizes H. pylori and enhances antibiotic therapy 
and its culture supernatants inhibit ulcer formation.
Fluoroquinolones are generally considered as the 
drugs of choice for the empirical treatment of diar-
rhea in adults, they are active against most of the 
common intestinal pathogens with excellent tissue 
and intracellular penetration, and achieve high fe-
cal concentrations and have a good safety profile 
in adults [23]. Therefore, we investigated the ef-
fect of L. acidophilus with presence of ciprofloxa-
cin against diarrhea causing bacteria in vitro. The 
MIC of ciprofloxacin alone against all tested strains 
was 15.625 μg/ml, while when combined with both 
lactobacilli supernatants, the MIC decreased signifi-
cantly to 0.488 μg/ml for ETEC, S. typhimurium and 
S.flexeneri and to 0.977 μg/ml for EHEC and S. au-
reus (P= 0.000). The overall results of this study are 
similar to results of Kaur and Sharma [24], which 
evaluated the synergism between conventional an-
tibiotics and the cell-free supernatant (CFS) of vagi-
nal Lactobacillus crispatus156 against P. aeruginosa 
MTCC 741 by checkerboard titrations. The used CFS 
succeeded to increase the activities of ciprofloxa-
cin, moxifloxacin, and streptomycin , and it has de-
creased the MIC of ciprofloxacin by 30 times and 
MICs of both moxifloxacin and streptomycin by 8 
times. 
In conclusion, this study suggests that L. aci-
dophilus can be used as an alternative therapy in 
treatment of different forms of infective bacterial 
gastroenteritis/diarrhea by its natural source in fer-
mented milk and yoghurt or as mediations. The 
combined therapy of L. acidophilus with ciprofloxa-
cin in treatment of infective gastroenteritis will help 
to decrease the required dose of ciprofloxacin and 
subsequent its potential side effects on intestinal 
bacterial flora.
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